Home › Funds › TrueWealth Advisors, LLC › IBD

TrueWealth Advisors, LLC position in IBD

NORTHERN LTS FD TR IV

TrueWealth Advisors, LLC reported holding 126,387 shares of IBD (NORTHERN LTS FD TR IV) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 0.65% of its reported portfolio and ranking #28 among its reported holdings. TrueWealth Advisors, LLC has disclosed IBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)126.39K sh
Reported value held$2.91M
Portfolio Weight0.65%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How TrueWealth Advisors, LLC's IBD position evolved

TrueWealth Advisors, LLC first disclosed a stake in IBD in Q3 2023 at 12,821 shares (US$290K). The position peaked in Q2 2026 at 123,684 shares, worth US$2.9M. Across 13 filings, TrueWealth Advisors, LLC increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 126,387 shares valued at US$2.9M — an increase of 2,703 shares quarter over quarter.. Notable position changes include a 137% increase in Q3 2024 (shares fell 3% over the following quarter), a 97% increase in Q1 2025 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.82K $290.27K New
Q4 2023 12.50K $294.83K Reduce
Q1 2024 12.68K $297.75K Add
Q2 2024 13.81K $322.07K Add
Q3 2024 32.73K $788.16K Add
Q4 2024 40.56K $950.70K Add
Q1 2025 80.06K $1.90M Add
Q2 2025 81.78K $1.96M Add
Q3 2025 84.28K $2.04M Add
Q4 2025 92.23K $2.23M Add
Q1 2026 110.27K $2.63M Add
Q2 2026 123.68K $2.94M Add
Q3 2026 126.39K $2.91M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBD and 13F data

IBD (NORTHERN LTS FD TR IV) is a company whose sector is not yet classified in our data. 30 other funds we track also report a position in IBD — the largest reported positions include Inspire Advisors, LLC (US$97.5M), Faithward Advisors, LLC (US$40.8M), CREATIVE FINANCIAL DESIGNS INC /ADV (US$23.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBD

All IBD fund holders →

FAQ

How long has TrueWealth Advisors, LLC held IBD?

TrueWealth Advisors, LLC has disclosed IBD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TrueWealth Advisors, LLC's current position in IBD?

As of Q3 2026, TrueWealth Advisors, LLC holds 126.39K shares of IBD (NORTHERN LTS FD TR IV), valued at $2.91M, representing 0.65% of its reported portfolio and ranking #28.

Has TrueWealth Advisors, LLC been buying or selling IBD?

In the latest 13F filing (Q3 2026), TrueWealth Advisors, LLC increased its position in IBD. The position peaked in Q2 2026 at 123.68K shares.

Which other funds hold IBD?

Other major institutional holders of IBD include Inspire Advisors, LLC, Faithward Advisors, LLC, CREATIVE FINANCIAL DESIGNS INC /ADV, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.